Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa

NCT02974348 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Drug Resistant Malaria Due to Plasmodium Falciparum

Interventions

DRUG: Arthemeter-lumefantrine
DRUG: Artesunate mefloquine
DRUG: Dihydroartemisinin piperaquine
DRUG: Paracetamol
DRUG: Amoxicillin
DRUG: Quinine

Sponsor

University of Bamenda

Collaborators

[object Object]
[object Object]